Narcotic Drugs Market Report 2026

Narcotic Drugs Market Overview

• Narcotic Drugs market size has reached to $14.71 billion in 2025 • Expected to grow to $18.79 billion in 2030 at a compound annual growth rate (CAGR) of 5.2% • Growth Driver: Role Of Rising Chronic Disease Incidence In Driving Growth Of The Narcotic Drug Market • Market Trend: Product Development And Innovation To Provide Reliable Products To Customers And Strengthen Market Position • Asia-Pacific was the largest region in 2025.

What Is Covered Under Narcotic Drugs Market?

A narcotic drug is a type of drug that acts on the central nervous system to produce sleepiness, pain relief, euphoria, and sometimes hallucinations. Narcotic drugs are typically derived from the opium poppy plant but can also be synthetically produced. The main drug types of narcotic drugs are opium, heroin, codeine, oxycodone, and others. Opium refers to a bitter, brownish, addictive substance made from the dried-out latex of premature opium poppies' seed capsules. The various sources include natural, semi-synthetic, and synthetic with various indications such as pain management, cough, diarrhea, dysentery, asthma, and others that are distributed through various distribution channels such as hospital pharmacies, online pharmacies, and retail pharmacies used by various end users such as hospitals, homecare, specialty clinics, others.

What Is The Narcotic Drugs Market Growth Forecast?

The narcotic drugs market size is expected to see strong growth in the next few years. It will grow to $18.79 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to growing demand for abuse-deterrent formulations, expansion of online pharmacy channels, advancements in synthetic narcotics production, rising focus on personalized pain management, increasing regulatory approvals for new narcotic drugs. Major trends in the forecast period include rise in prescription drug monitoring programs, growth of pain management therapies, increasing abuse-deterrent formulations, expansion of specialty pharmacies, development of synthetic narcotics.

Global Narcotic Drugs Market Segmentation

1) By Drug: Opium, Heroin, Codeine, Oxycodone, Other Drugs 2) By Source: Natural, Semi-Synthetic, Synthetic 3) By Indication: Pain Management, Cough, Diarrhea, Dysentery, Other Indications 4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy 5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users Subsegments: 1) By Opium: Raw Opium, Opium Extracts, Opium Derivatives 2) By Heroin: Diacetylmorphine, Heroin Hydrochloride, Heroin Acetate 3) By Codeine: Codeine Phosphate, Codeine Sulfate 4) By Oxycodone: Oxycodone Hydrochloride, Oxycodone Acetaminophen, Controlled-Release Oxycodone 5) By Other Drugs: Fentanyl, Morphine, Hydromorphone, Methadone, Buprenorphine

What Is The Driver Of The Narcotic Drugs Market?

The rising incidence of chronic diseases is expected to propel the growth of the narcotic drug market going forward. Chronic disease is a form of illness that lasts three months or more and can deteriorate with time. Narcotic drugs are used to manage chronic diseases to relieve cancer, chronic pain syndrome, terminal illness, and severe arthritis. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the rising incidence of chronic diseases is driving the growth of the narcotic drug industry.

Key Players In The Global Narcotic Drugs Market

Major companies operating in the narcotic drugs market are Pfizer Inc., Johnson and Johnson Limited, AbbVie Inc., Novartis AG, AstraZeneca PLC, Sanofi S.A., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma LP, Hikma Pharmaceuticals Plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals, Alvogen Inc., Indivior Inc., Impax Laboratories Inc., Collegium Pharmaceutical Inc., Lannett Co Inc., Par Pharmaceutical Inc., West-Ward Pharmaceuticals Corp.

Global Narcotic Drugs Market Trends and Insights

Major companies operating in the narcotic drug market increasingly focus on product development and innovation to provide reliable products to their customers and strengthen their market position. For instance, in May 2023, Indivior PLC, a US-based pharmaceutical company, launched OPVEE (nalmefene) nasal spray, an opioid overdose rescue medicine for natural and synthetic opioids like fentanyl. It is recommended to immediately treat known or suspected opioid overdoses with natural or synthetic opioids in adults and pediatric patients 12 years of age and older, as indicated by respiratory and central nervous system depression.

What Are Latest Mergers And Acquisitions In The Narcotic Drugs Market?

In March 2023, Indivior PLC, a US-based pharmaceutical company, acquired Opiant Pharmaceuticals Inc. for $145 million. With this acquisition, Indivior PLC aims to strengthen its addiction treatment and science portfolio, notably through OPNT003, an investigational opioid overdose treatment designed to offer an important treatment option to address the current wave of US opioid overdoses from potent synthetic opioids, such as fentanyl. Opiant Pharmaceuticals Inc. is a US-based pharmaceutical company that manufactures narcotic drugs.

Regional Insights

Asia-Pacific was the largest region in the narcotic drugs market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Narcotic Drugs Market?

The narcotic drug market consists of sales of ketobemidone, pethidine, tolidine, and trimeperidine. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Narcotic Drugs Market Report 2026?

The narcotic drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the narcotic drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.